• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在一名无心脏病患者口服索他洛尔预防房颤复发治疗早期出现持续性尖端扭转型室速。

Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.

作者信息

D'Aloia Antonio, Faggiano Pompilio, Brentana Loretta, Boldini Alessandra, Pedrinazzi Claudio, Procopio Roberto, Dei Cas Livio

出版信息

Int J Cardiol. 2005 Dec 7;105(3):337-9. doi: 10.1016/j.ijcard.2004.11.031. Epub 2005 Jun 27.

DOI:10.1016/j.ijcard.2004.11.031
PMID:15985302
Abstract

This report describes a 64 year-old female patient admitted to our department for recurrent and symptomatic episodes of atrial fibrillation. Antiarrhythmic therapy with sotalol at 240 mg/day was started, and after 48 h the patient experienced several episodes of sustained torsade de pointes, dramatic marked QT interval prolongation and negative T wave, in absence of overt cardiac disease, renal failure, electrolyte abnormalities or baseline QT interval prolongation. This case emphasizes the importance of hospitalization at the starting of sotalol therapy, especially in female patients, even in absence of predisposing factors for drug-induced tachyarrhythmias.

摘要

本报告描述了一名64岁女性患者,因反复发作且有症状的房颤发作而入住我科。开始使用索他洛尔进行抗心律失常治疗,剂量为每日240毫克,48小时后,患者出现多次持续性尖端扭转型室速发作、显著的QT间期延长和负向T波,且无明显的心脏病、肾衰竭、电解质异常或基线QT间期延长。该病例强调了索他洛尔治疗开始时住院治疗的重要性,尤其是在女性患者中,即使不存在药物性快速心律失常的诱发因素。

相似文献

1
Sustained torsade de pointes occurring early during oral sotalol therapy for atrial fibrillation recurrence prophylaxis in a patient without heart disease.在一名无心脏病患者口服索他洛尔预防房颤复发治疗早期出现持续性尖端扭转型室速。
Int J Cardiol. 2005 Dec 7;105(3):337-9. doi: 10.1016/j.ijcard.2004.11.031. Epub 2005 Jun 27.
2
[Torsade de Pointes tachycardia during sotalol treatment of a patient with normal potassium levels].[索他洛尔治疗血钾水平正常患者期间发生尖端扭转型室性心动过速]
Ugeskr Laeger. 1996 Jul 8;158(28):4093-4.
3
[QT prolongation and torsade de pointes tachycardia during therapy with maprotiline. Differential diagnostic and therapeutic aspects].[米安色林治疗期间的QT间期延长和尖端扭转型室性心动过速。鉴别诊断和治疗方面]
Dtsch Med Wochenschr. 2001 Dec 7;126(49):1396-400. doi: 10.1055/s-2001-18880.
4
Drug-induced torsade de pointes.药物性尖端扭转型室性心动过速
Clin Pharm. 1985 Nov-Dec;4(6):675-90.
5
Baseline values and sotalol-induced changes of ventricular repolarization duration, heterogeneity, and instability in patients with a history of drug-induced torsades de pointes.有药物性尖端扭转型室性心动过速病史患者的基线值以及索他洛尔引起的心室复极持续时间、异质性和不稳定性的变化。
J Clin Pharmacol. 2009 Jan;49(1):6-16. doi: 10.1177/0091270008325927. Epub 2008 Oct 28.
6
Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.环丙沙星在一名接受Ⅲ类抗心律失常治疗的患者中诱发了获得性长QT综合征。
Cardiol J. 2009;16(2):172-4.
7
Monotherapy versus combination therapy with class III antiarrhythmic agents to attenuate transmural dispersion of repolarization: a potential risk factor for torsade de pointes.使用III类抗心律失常药物进行单药治疗与联合治疗以减轻复极跨壁离散度:尖端扭转型室速的一个潜在危险因素
Pharmacotherapy. 2007 Sep;27(9):1297-305. doi: 10.1592/phco.27.9.1297.
8
Torsades de pointes with administration of high-dose intravenous d-sotalol to a patient with congestive heart failure.充血性心力衰竭患者静脉注射大剂量d-索他洛尔后发生尖端扭转型室速。
Pharmacotherapy. 1997 Jul-Aug;17(4):830-1.
9
[Sotalol--atrial fibrillation, reduced renal function and sudden death].[索他洛尔——心房颤动、肾功能减退与猝死]
Tidsskr Nor Laegeforen. 1998 Oct 30;118(26):4086-7.
10
[Sotalol and torsades de pointes ventricular tachycardia].[索他洛尔与尖端扭转型室性心动过速]
Ugeskr Laeger. 1996 May 6;158(19):2711-6.